Nariaki Matsuura∥

Kyoto Medical Center — Japan

Medicine · Health Sciences

73h-index16.5kcitations417works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(36), Cancer-related Molecular Pathways(35), Cell Adhesion Molecules Research(29), Peptidase Inhibition and Analysis(22), Glycosylation and Glycoproteins Research(21)

Publications417 total

Potential of Bone MR Imaging for Evaluating the Meniscus
Japanese Journal of Magnetic Resonance in Medicine·2025Open Access
Circulating tumor-associated antigen-specific IFNγ+4-1BB+ CD8+ T cells as peripheral biomarkers of treatment outcomes in patients with pancreatic cancer
Frontiers in Immunology·2024· 2 citedOpen Access
Histone methyltransferase SUV39H1 regulates the Golgi complex via the nuclear envelope-spanning LINC complex
PLoS ONE·2023· 6 citedOpen Access
Association between Genetic Variation in the TAS2R38 Bitter Taste Receptor and Propylthiouracil Bitter Taste Thresholds among Adults Living in Japan Using the Modified 2AFC Procedure with the Quest Method
Nutrients·2023· 8 citedOpen Access
Supplementary Data from <i>Jumonji Domain Containing 1A</i> Is a Novel Prognostic Marker for Colorectal Cancer: <i>In vivo</i> Identification from Hypoxic Tumor Cells
2023Open Access
Data from <i>Jumonji Domain Containing 1A</i> Is a Novel Prognostic Marker for Colorectal Cancer: <i>In vivo</i> Identification from Hypoxic Tumor Cells
2023Open Access
Supplementary Figure S1. Flow chart of LN sampling and RT-PCR. from Micrometastasis Volume in Lymph Nodes Determines Disease Recurrence Rate of Stage II Colorectal Cancer: A Prospective Multicenter Trial
2023Open Access
Data from Micrometastasis Volume in Lymph Nodes Determines Disease Recurrence Rate of Stage II Colorectal Cancer: A Prospective Multicenter Trial
2023Open Access
Supplementary Data from <i>Jumonji Domain Containing 1A</i> Is a Novel Prognostic Marker for Colorectal Cancer: <i>In vivo</i> Identification from Hypoxic Tumor Cells
2023Open Access
Supplementary Figures S8-9. from Micrometastasis Volume in Lymph Nodes Determines Disease Recurrence Rate of Stage II Colorectal Cancer: A Prospective Multicenter Trial
2023Open Access
Supplementary Figures S8-9. from Micrometastasis Volume in Lymph Nodes Determines Disease Recurrence Rate of Stage II Colorectal Cancer: A Prospective Multicenter Trial
2023Open Access
Supplementary Figure S4. Randomization of chemotherapy in CEA band-positive CRC cases. from Micrometastasis Volume in Lymph Nodes Determines Disease Recurrence Rate of Stage II Colorectal Cancer: A Prospective Multicenter Trial
2023Open Access
Supplementary Figure S3. Survival analyses stratified by qRT-PCR (group a vs group b, vs group c+d). from Micrometastasis Volume in Lymph Nodes Determines Disease Recurrence Rate of Stage II Colorectal Cancer: A Prospective Multicenter Trial
2023Open Access
Supplementary Figure S7. Micrometastasis stayed mostly at pericolic nodes in node- negative CRCs. from Micrometastasis Volume in Lymph Nodes Determines Disease Recurrence Rate of Stage II Colorectal Cancer: A Prospective Multicenter Trial
2023Open Access
Supplementary Figures S5-6. from Micrometastasis Volume in Lymph Nodes Determines Disease Recurrence Rate of Stage II Colorectal Cancer: A Prospective Multicenter Trial
2023Open Access
Supplementary Figure S4. Randomization of chemotherapy in CEA band-positive CRC cases. from Micrometastasis Volume in Lymph Nodes Determines Disease Recurrence Rate of Stage II Colorectal Cancer: A Prospective Multicenter Trial
2023Open Access
Data from <i>Jumonji Domain Containing 1A</i> Is a Novel Prognostic Marker for Colorectal Cancer: <i>In vivo</i> Identification from Hypoxic Tumor Cells
2023Open Access
Data from Micrometastasis Volume in Lymph Nodes Determines Disease Recurrence Rate of Stage II Colorectal Cancer: A Prospective Multicenter Trial
2023Open Access
Supplementary Figure S7. Micrometastasis stayed mostly at pericolic nodes in node- negative CRCs. from Micrometastasis Volume in Lymph Nodes Determines Disease Recurrence Rate of Stage II Colorectal Cancer: A Prospective Multicenter Trial
2023Open Access
Supplementary Figures S5-6. from Micrometastasis Volume in Lymph Nodes Determines Disease Recurrence Rate of Stage II Colorectal Cancer: A Prospective Multicenter Trial
2023Open Access
page 1 of 21Next →

Frequent Co-authors

Morito Monden(15), Hirofumi Yamamoto(10), Masato Sakon(8), Hiroaki Nagano(7), Keizo Dono(7), Naomasa Kawaguchi(7), Masahiko Tsujimoto(6), Koji Umeshita(6), Shoji Nakamori(6), Yoshiki Sawa(6), Mitsugu Sekimoto(5), Shigeki Higashiyama(5), Shigeru Miyagawa(5), Katsuhide Yoshidome(4), Yasuhiro Ito(4), Jiro Okami(4), Teruo Okano(4), Goro Matsumiya(4), Yuhki Yokoyama(4), Atsuhiro Saito(4)